Skip to Content

The interim authorization for the COVID-19 Vaccine Moderna emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore is made under Regulations 60A(4) and (5)(b) of the Health Product (Therapeutic Products) Regulations, for use and supply as directed by the Government of Singapore.

Patient Information Leaflet

Summary of Product Characteristics

Storage, Handling, Dosage and Administration